Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kawasaki disease

D Y Leung1

  • 1Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.

Current Opinion in Rheumatology
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Early recognition and treatment of Kawasaki disease (KD) in children can prevent heart issues. Recent research suggests a superantigen may trigger the immune response in KD, guiding future studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus guidelines for interventional cardiology services delivery during covid-19 pandemic in Australia and new Zealand.

Heart, lung & circulation·2020
Same author

Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis.

The British journal of dermatology·2017
Same author

Induction of glucocorticoid receptor-beta expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2010
Same author

Tissue Doppler echocardiography.

Minerva cardioangiologica·2010
Same author

Advanced applications of 3-dimensional echocardiography.

Minerva cardioangiologica·2009
Same author

How compliant are we with guidelines for coronary angiography in clinical practice?

Internal medicine journal·2007
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Cardiovascular Medicine

Background:

  • Kawasaki disease (KD) is a critical pediatric illness causing vasculitis, potentially leading to myocarditis and coronary artery abnormalities.
  • Cardiovascular complications in KD significantly impact long-term health outcomes for affected children.
  • Current treatment involves high-dose intravenous immunoglobulin (IVIG) within 10 days of illness onset to mitigate these risks.

Purpose of the Study:

  • To summarize recent findings on the etiology and pathogenesis of Kawasaki disease.
  • To highlight the role of superantigens in the immune activation observed in KD.
  • To emphasize the importance of early diagnosis and prompt treatment for improved patient outcomes.

Main Methods:

  • Review of recent studies investigating the immune response in Kawasaki disease.

Related Experiment Videos

  • Analysis of potential etiologic agents, focusing on superantigens.
  • Correlation of treatment timing with the prevalence of cardiovascular abnormalities.

    • Main Results:

    • High-dose intravenous immunoglobulin (2 g/kg) administered within the first 10 days of illness significantly reduces cardiovascular abnormalities.
    • Strong evidence suggests a superantigen is involved in the massive immune activation characteristic of KD.
    • Understanding the causative agent is crucial for facilitating early recognition and treatment.

    Conclusions:

    • Prompt treatment of Kawasaki disease with high-dose IVIG is vital for preventing severe cardiovascular complications.
    • Superantigen involvement in immune activation presents a promising new avenue for KD etiology research.
    • Further investigation into the role of superantigens may lead to novel diagnostic and therapeutic strategies for Kawasaki disease.